Alume Biosciences Inc
Biotechnology company · La Jolla, California, United States
Alume Biosciences Inc is a biotechnology company headquartered in La Jolla, California, United States. Its earliest recorded incorporation is in 2017. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $8 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $2.2 million sold in a notice filed in 2026.
Alume Biosciences at a glance
What does Alume Biosciences do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $8 million in total (2019 to 2023). NIH funding came from the National Institute of Neurological Disorders and Stroke, National Cancer Institute.
Private fundraising reported to the SEC
12 Form D notices; the most recent reported $2.2 million sold (2026).
Frequently asked questions about Alume Biosciences
Where is Alume Biosciences headquartered?
Alume Biosciences Inc is headquartered in La Jolla, California, United States.
What does Alume Biosciences do?
Alume Biosciences Inc is a biotechnology company.
When was Alume Biosciences founded?
The earliest incorporation on record for Alume Biosciences Inc is in 2017, according to public company registers.
Similar companies
- Inhibrx, Inc.La Jolla, California, United States
- Zura Bio LtdLa Jolla, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.